{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,23]],"date-time":"2026-07-23T02:00:55Z","timestamp":1784772055963,"version":"3.55.0"},"reference-count":54,"publisher":"MDPI AG","issue":"14","license":[{"start":{"date-parts":[[2026,7,22]],"date-time":"2026-07-22T00:00:00Z","timestamp":1784678400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Diagnostics"],"abstract":"<jats:p>Obesity is a chronic, relapsing disease and a significant oncological risk factor. The correlation is most pronounced and consistent for endometrial cancer. Conversely, evidence linking obesity to ovarian cancer is less robust and varies by histotype, while the association with cervical cancer is influenced by factors related to screening, diagnosis, treatment, and survival. This review examines obesity, particularly class III (morbid) obesity, in relation to the risk of gynaecological cancer, diagnostic approaches, and management strategies. A structured narrative review of PubMed\/MEDLINE, Cochrane Library, Scopus and Web of Science Core Collection was conducted for literature published between January 2000 and December 2025. Eligible evidence included systematic reviews, meta-analyses, cohort and case\u2013control studies, mechanistic studies and clinical guidance relevant to obesity and endometrial, ovarian or cervical cancer. Title\/abstract screening and full-text selection were conducted using predefined criteria for conceptual relevance and clinical applicability. Excess adiposity contributes to endometrial carcinogenesis through hormonal dysregulation, insulin resistance and hyperinsulinaemia, adipokine imbalance, chronic inflammation, and oxidative stress. In ovarian cancer, associations are generally weaker but appear more relevant for selected histological subtypes and cumulative adiposity exposure. In cervical cancer, obesity should not be interpreted as replacing HPV-driven pathogenesis; rather, it may affect screening adequacy, treatment selection, perioperative risk, and disease-specific survival in morbidly obese patients. Current evidence does not support morbid obesity as an independent driver of all gynaecological cancers. It supports obesity as a major modifiable risk factor and clinical modifier, particularly for endometrial cancer, and highlights the need for pragmatic risk stratification based on BMI class, adiposity distribution, metabolic comorbidity, functional status and cancer-site-specific pathways. Biomarker evidence remains hypothesis-generating, and obesity-integrated oncological pathways require prospective validation in patients with a BMI \u2265 40 kg\/m2.<\/jats:p>","DOI":"10.3390\/diagnostics16142295","type":"journal-article","created":{"date-parts":[[2026,7,23]],"date-time":"2026-07-23T01:01:28Z","timestamp":1784768488000},"page":"2295","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Obesityand Gynaecological Cancers, with a Focus on Morbid Obesity: Risk Stratification, Early Diagnosis and Management"],"prefix":"10.3390","volume":"16","author":[{"given":"Magdalena","family":"Bizo\u0144","sequence":"first","affiliation":[{"name":"LUX MED Oncology Hospital, ul. Szamocka 6, 01-748 Warsaw, Poland"},{"name":"Wy\u017csza Szko\u0142a Nauk Medycznych LUX MED, ul. Szturmowa 2, 02-678 Warsaw, Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karolina","family":"Piotrowska-Lis","sequence":"additional","affiliation":[{"name":"LUX MED Oncology Hospital, ul. Szamocka 6, 01-748 Warsaw, Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna","family":"Sztokinier","sequence":"additional","affiliation":[{"name":"LUX MED Oncology Hospital, ul. Szamocka 6, 01-748 Warsaw, Poland"},{"name":"Public Health Care Centre, Blessed Virgin Mary Hospital, ul. Starowiejska 15, 08-110 Siedlce, Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6122-9755","authenticated-orcid":false,"given":"Justyna","family":"Domienik-Kar\u0142owicz","sequence":"additional","affiliation":[{"name":"Wy\u017csza Szko\u0142a Nauk Medycznych LUX MED, ul. Szturmowa 2, 02-678 Warsaw, Poland"},{"name":"LUX MED Group Ltd., 02-678 Warsaw, Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maciej","family":"Olszewski","sequence":"additional","affiliation":[{"name":"LUX MED Oncology Hospital, ul. Szamocka 6, 01-748 Warsaw, Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna","family":"Rulkiewicz","sequence":"additional","affiliation":[{"name":"LUX MED Group Ltd., 02-678 Warsaw, Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2026,7,22]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"1077","DOI":"10.7150\/jca.91471","article-title":"The effectiveness of metabolic bariatric surgery in preventing gynecologic cancer\u2014From pathophysiology to clinical outcomes","volume":"15","author":"Machairiotis","year":"2024","journal-title":"J. Cancer"},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1016\/j.ygyno.2024.10.004","article-title":"Tirzepatide as an innovative treatment strategy in a pre-clinical model of obesity-driven endometrial cancer","volume":"191","author":"Kong","year":"2024","journal-title":"Gynecol. Oncol."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1038\/nrc1408","article-title":"Overweight, obesity and cancer: Epidemiological evidence and proposed mechanisms","volume":"4","author":"Calle","year":"2004","journal-title":"Nat. Rev. Cancer"},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"794","DOI":"10.1056\/NEJMsr1606602","article-title":"Body fatness and cancer\u2014Viewpoint of the IARC Working Group","volume":"375","author":"Scoccianti","year":"2016","journal-title":"N. Engl. J. Med."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1007\/s12032-023-01957-3","article-title":"Epidemiological Trends and Risk Factors of Gynaecological Cancers: An Update","volume":"40","author":"Keyvani","year":"2023","journal-title":"Med. Oncol."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"742","DOI":"10.1016\/j.soard.2023.01.025","article-title":"Excess body fatness and cancer risk: A summary of the epidemiologic evidence","volume":"19","author":"Patel","year":"2023","journal-title":"Surg. Obes. Relat. Dis."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"1033","DOI":"10.2174\/1389200221666200103113330","article-title":"Role of Adiponectin in Cervical Cancer","volume":"20","author":"Soumya","year":"2019","journal-title":"Curr. Drug Metab."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"1268","DOI":"10.1007\/s12672-025-03111-z","article-title":"Exploring the causal relationship between obesity, immune cell characteristics and cervical cancer risk using Mendelian randomisation","volume":"16","author":"Cui","year":"2025","journal-title":"Discov. Oncol."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1186\/s40170-025-00398-y","article-title":"Obesity and cervical intraepithelial neoplasia: Regulation of mitochondrial energy metabolism via the Kisspeptin\/GPR54 signaling pathway","volume":"13","author":"Pan","year":"2025","journal-title":"Cancer Metab."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"1098","DOI":"10.1097\/AOG.0000000000000558","article-title":"Morbid obesity as an independent risk factor for disease-specific mortality in women with cervical cancer","volume":"124","author":"Frumovitz","year":"2014","journal-title":"Obstet. Gynecol."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"5965","DOI":"10.21037\/tcr-2025-1865","article-title":"Association between the age-adjusted visceral adiposity index (AVAI) and gynecologic malignancies: A cross-sectional study based on NHANES data","volume":"14","author":"Zhang","year":"2025","journal-title":"Transl. Cancer Res."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1002\/ijgo.70156","article-title":"Environment, lifestyle and cancer in women","volume":"171","author":"Farina","year":"2025","journal-title":"Int. J. Gynaecol. Obstet."},{"key":"ref_13","first-page":"229","article-title":"Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"74","author":"Bray","year":"2024","journal-title":"CA Cancer J. Clin."},{"key":"ref_14","first-page":"710","article-title":"Interpretation on the report of global cancer statistics 2022","volume":"46","author":"Zhang","year":"2024","journal-title":"Zhonghua Zhong Liu ZA Zhi [Chin. J. Oncol.]"},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1016\/S0140-6736(08)60269-X","article-title":"Body-mass index and incidence of cancer: A systematic review and meta-analysis of prospective observational studies","volume":"371","author":"Renehan","year":"2008","journal-title":"Lancet"},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"1635","DOI":"10.1093\/annonc\/mdv142","article-title":"Anthropometric factors and endometrial cancer risk: A systematic review and dose\u2013response meta-analysis of prospective studies","volume":"26","author":"Aune","year":"2015","journal-title":"Ann. Oncol."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"e31","DOI":"10.3346\/jkms.2025.40.e31","article-title":"Different Patterns of the Relationship Between Gynaecological Malignancy and Obesity Index: A Nationwide Retrospective Cohort Study in Korea","volume":"40","author":"Kang","year":"2025","journal-title":"J. Korean Med. Sci."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1530\/ERC-12-0395","article-title":"Obesity and risk of ovarian cancer subtypes: Evidence from the Ovarian Cancer Association Consortium","volume":"20","author":"Olsen","year":"2013","journal-title":"Endocr. Relat. Cancer."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"209","DOI":"10.4274\/tjod.galenos.2020.83773","article-title":"The impact of morbid obesity on survival of endometrial cancer","volume":"17","author":"Guzel","year":"2020","journal-title":"Turk. J. Obstet. Gynecol."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/j.ygyno.2014.01.041","article-title":"The impact of obesity on surgical staging, complications, and survival with uterine cancer: A Gynecologic Oncology Group LAP2 ancillary data study","volume":"133","author":"Gunderson","year":"2014","journal-title":"Gynecol. Oncol."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"562","DOI":"10.1007\/s11701-025-02744-0","article-title":"Advanced robotic surgery in obese patients with gynecological cancers: Tips and tricks from literature to clinical practice","volume":"19","author":"Bruni","year":"2025","journal-title":"J. Robot. Surg."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1080\/13645706.2024.2407845","article-title":"Robotic-assisted, laparoscopic, and vaginal hysterectomy in morbidly obese patients with endometrial hyperplasia and endometrial cancer","volume":"33","author":"Giannini","year":"2024","journal-title":"Minim. Invasive Ther. Allied Technol."},{"key":"ref_23","doi-asserted-by":"crossref","unstructured":"Arcieri, M., Paparcura, F., Giorgiutti, C., Taliento, C., Bogani, G., Driul, L., Greco, P., Arcoli, A., Chiantera, V., and Fanfani, F. (2025). Robotic surgery in severly obese frail patients for the treatment of atypical endometrial hyperplasia and endometrial cancer: A propensity-match analysis at an ESGO-accredited center. Cancers, 17.","DOI":"10.3390\/cancers17030482"},{"key":"ref_24","first-page":"96","article-title":"Does obesity hinder radiotherapy in endometrial cancer patients? The implementation of new technique in adjuvant radiotherapy\u2014Focus on obese patients","volume":"13","author":"Gottwald","year":"2014","journal-title":"Prz. Menopauzalny"},{"key":"ref_25","doi-asserted-by":"crossref","unstructured":"Hooks, O., Jhumkhwala, V., Sibson, K., Shrontz, A., Krishnan, S.S., and Ahmad, S. (2025). Diabetes, obesity, and endometrial cancer: A review. Curr. Oncol., 32.","DOI":"10.3390\/curroncol32120672"},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"e71007","DOI":"10.1002\/cam4.71007","article-title":"Exploring the Relationship Between Adipocytokines and Endometrial Cancer: Identifying Correlations with Clinico-Pathological Prognostic Factors","volume":"14","author":"Ray","year":"2025","journal-title":"Cancer Med."},{"key":"ref_27","doi-asserted-by":"crossref","unstructured":"Khatun, M., Urpilainen, E., Ahtikoski, A., Arffman, R.K., Pasanen, A., Puistola, U., Tapanainen, J.S., Andersson, L.C., Butzow, R., and Loukovaara, M. (2021). Low Expression of Stanniocalcin 1 (STC-1) Protein Is Associated with Poor Clinicopathologic Features of Endometrial Cancer. Pathol. Oncol. Res., 27.","DOI":"10.3389\/pore.2021.1609936"},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"e240228","DOI":"10.1530\/ERC-24-0228","article-title":"ob\/ob obese mice promote tumorigenesis of endometrial cancer associated with Pten deficiency","volume":"32","author":"Kim","year":"2025","journal-title":"Endocr. Relat. Cancer."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"37438","DOI":"10.1038\/s41598-025-21347-1","article-title":"Diagnostic role of galanin in distinguishing endometrial atypical hyperplasia and carcinoma from benign endometrial conditions","volume":"15","author":"Ata","year":"2025","journal-title":"Sci. Rep."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"1010","DOI":"10.1136\/ijgc-2019-000495","article-title":"Using quality improvement to increase the awareness of obesity among endometrial cancer patients","volume":"29","author":"Torres","year":"2019","journal-title":"Int. J. Gynecol. Cancer"},{"key":"ref_31","first-page":"2311","article-title":"Sleep, Quality of Life, and Depression in Endometrial Cancer Survivors with Obesity Seeking Weight Loss","volume":"28","author":"Nock","year":"2020","journal-title":"Support. Care Cancer"},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"1121","DOI":"10.2215\/CJN.09011010","article-title":"Cancer-specific mortality in chronic kidney disease: Longitudinal follow-up of a large cohort","volume":"6","author":"Weng","year":"2011","journal-title":"Clin. J. Am. Soc. Nephrol."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1007\/s11255-019-02324-w","article-title":"The Association of the Decline in Glomerular Filtration Rate with Aggressive Endometrial Cancers","volume":"52","author":"Premuzic","year":"2020","journal-title":"Int. Urol. Nephrol."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"3401957","DOI":"10.1155\/humu\/3401957","article-title":"Causal Relationships Between Pregnancy, Menstrual History, and Endometrial Cancer with Mediating Effects of Metabolism-Related Traits","volume":"2025","author":"Zhou","year":"2025","journal-title":"Hum. Mutat."},{"key":"ref_35","doi-asserted-by":"crossref","unstructured":"Shea, A.A., Heffron, C.L., Grieco, J.P., Roberts, P.C., and Schmelz, E.M. (2024). Obesity modulates the cellular and molecular microenvironment in the peritoneal cavity: Implications for ovarian cancer risk. Front. Immunol., 14.","DOI":"10.3389\/fimmu.2023.1323399"},{"key":"ref_36","doi-asserted-by":"crossref","unstructured":"Assidi, M., Yahya, F.M., Al-Zahrani, M.H., Elkhatib, R., Zari, A., Elaimi, A., Al-Maghrabi, J., Dallol, A., Buhmeida, A., and Abu-Elmagd, M. (2021). Leptin Protein Expression and Promoter Methylation in Ovarian Cancer: A Strong Prognostic Value with Theranostic Promises. Int. J. Mol. Sci., 22.","DOI":"10.3390\/ijms222312872"},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/978-3-319-42542-9_1","article-title":"Obesity and cancer","volume":"208","author":"Pischon","year":"2016","journal-title":"Recent Results Cancer Res."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"1625","DOI":"10.1056\/NEJMoa021423","article-title":"Overweight, obesity, and mortality from cancer in prospectively studied cohort of U.S. adults","volume":"348","author":"Calle","year":"2003","journal-title":"N. Engl. J. Med."},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1007\/s11701-025-02739-x","article-title":"Saturation of respiratory strain during robotic hysterectomy in obese women with endometrial cancer","volume":"19","author":"Kost","year":"2025","journal-title":"J. Robot. Surg."},{"key":"ref_40","first-page":"70172","article-title":"A single arm pilot observational study to evaluate the safety and feasibility of a pre-operative very low calorie diet in severely obese patients with endometrial cancer","volume":"8","author":"Ayres","year":"2025","journal-title":"Cancer Rep."},{"key":"ref_41","doi-asserted-by":"crossref","unstructured":"Hagemann, A.R., Hagemann, I.S., Mutch, D.G., Devor, E.J., Malmrose, P.K., Zhang, Y., Morrison, A.M., Thiel, K.W., and Leslie, K.K. (2025). Enhancing progestin therapy with a glucagon-like peptide 1 agonist for the conservative management of endometrial cancer. Cancers, 17.","DOI":"10.3390\/cancers17040598"},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"1183","DOI":"10.1016\/j.soard.2024.08.033","article-title":"Multi-society clinical practice guidance for the safe use of glucagon-like peptide-1 receptor agonists in the perioperative period","volume":"20","author":"Kindel","year":"2024","journal-title":"Surg. Obes. Relat. Dis."},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1016\/S1470-2045(09)70159-7","article-title":"Effects of bariatric surgery on cancer incidence in obese patients in Sweden (Swedish Obese Subjects Study): A prospective controlled intervention trial","volume":"10","author":"Gummesson","year":"2009","journal-title":"Lancet Oncol."},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"2423","DOI":"10.1001\/jama.2022.9009","article-title":"Association of bariatric surgery with cancer risk and mortality in adults with obesity","volume":"327","author":"Aminian","year":"2022","journal-title":"JAMA"},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"1433","DOI":"10.1007\/s11695-018-3151-x","article-title":"Does bariatric surgery affect the incidence of endometrial cancer development? A systematic review","volume":"28","author":"Winder","year":"2018","journal-title":"Obes. Surg."},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"E423","DOI":"10.1016\/S1470-2045(25)00167-6","article-title":"ESGO\u2013ESTRO\u2013ESP guidelines for the management of patients with endometrial carcinoma: Update 2025","volume":"26","author":"Concin","year":"2025","journal-title":"Lancet Oncol."},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1002\/ijgo.14923","article-title":"FIGO staging of endometrial cancer: 2023","volume":"162","author":"Berek","year":"2023","journal-title":"Int. J. Gynecol. Obstet."},{"key":"ref_48","doi-asserted-by":"crossref","unstructured":"Zhu, M., Zhang, Y., Bao, X., Zhu, H., and Jin, W. (2025). Association between childhood adiposity and gynecologic cancers: A mendelian randomization analysis. BMC Women\u2019s Health, 25.","DOI":"10.1186\/s12905-025-04010-9"},{"key":"ref_49","first-page":"79","article-title":"Diverging global incidence trends of early-onset cancers: Comparisons with incidence trends of later-onset cancers and mortality trends of early-onset cancers","volume":"12","author":"Terashima","year":"2025","journal-title":"Mil. Med. Res."},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"2439","DOI":"10.1007\/s10815-022-02625-7","article-title":"A brief insight into the etiology, genetics, and immunology of polycystic ovarian syndrome (PCOS)","volume":"39","author":"Siddiqui","year":"2022","journal-title":"J. Assist. Reprod. Genet."},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"40594","DOI":"10.1038\/s41598-025-24285-0","article-title":"Age, lifestyle, and disease affect ciliary transport in the human fallopian tube","volume":"15","author":"Neville","year":"2025","journal-title":"Sci. Rep."},{"key":"ref_52","doi-asserted-by":"crossref","unstructured":"Practice Committee of the American Society for Reproductive Medicine (2024). Fertility drugs and cancer: A guideline. Fertil. Steril., 122, 406\u2013420.","DOI":"10.1016\/j.fertnstert.2024.03.026"},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"102379","DOI":"10.1016\/j.bpobgyn.2023.102379","article-title":"Challenges of morbid obesity in gynecological practice","volume":"90","author":"Opoku","year":"2023","journal-title":"Best Pr. Res. Clin. Obstet. Gynaecol."},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"2037","DOI":"10.1200\/JCO.21.00471","article-title":"Appropriate systemic therapy dosing for obese adult patients with cancer: ASCO guideline update","volume":"39","author":"Griggs","year":"2021","journal-title":"J. Clin. Oncol."}],"container-title":["Diagnostics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2075-4418\/16\/14\/2295\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,23]],"date-time":"2026-07-23T01:09:35Z","timestamp":1784768975000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2075-4418\/16\/14\/2295"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,22]]},"references-count":54,"journal-issue":{"issue":"14","published-online":{"date-parts":[[2026,7]]}},"alternative-id":["diagnostics16142295"],"URL":"https:\/\/doi.org\/10.3390\/diagnostics16142295","relation":{},"ISSN":["2075-4418"],"issn-type":[{"value":"2075-4418","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,22]]}}}